re: hit 7.7///some reasons offered And with their completion of their production facility in Israel next year contracts will continue to flow.And a T/o attempt is certain.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%